Feelux acquires US drug developers at W38b
[DISCLOSURE] Feelux (033180) announced on April 13 that it has acquired 100 percent stakes in TJU Asset Management and Penn Life Science at 37.8 billion won (US$35.24 million).
By Hwang You-mee (glamazon@heraldcorp.com)